top of page

Advances in Perfusion Imaging for Ischemic Stroke Treatment Selection

  • Apr 21, 2025
  • 2 min read

Medical professional overseeing a patient undergoing advanced perfusion imaging to enhance ischemic stroke treatment selection.
Medical professional overseeing a patient undergoing advanced perfusion imaging to enhance ischemic stroke treatment selection.

Ischemic stroke, caused by an obstruction in a cerebral blood vessel, remains a leading cause of disability and death worldwide. Prompt and precise treatment is crucial to minimize brain damage and improve outcomes. In recent years, advancements in perfusion imaging have significantly enhanced clinicians' ability to identify viable brain tissue, determine the extent of ischemia, and guide therapeutic decisions. This article explores the key developments in perfusion imaging and their transformative impact on ischemic stroke treatment selection.


Understanding Perfusion Imaging:

 Perfusion imaging evaluates the passage of blood through the brain’s vascular system, helping clinicians visualize areas with reduced blood flow. This technique is critical for distinguishing between the ischemic core (irreversibly damaged tissue) and the penumbra (salvageable tissue at risk). By accurately identifying these zones, physicians can make informed decisions about treatment eligibility, especially for reperfusion therapies such as intravenous thrombolysis and mechanical thrombectomy.


Advanced Imaging Techniques: Recent years have seen notable progress in perfusion imaging modalities. Computed Tomography Perfusion (CTP) and Magnetic Resonance Perfusion (MRP) have emerged as standard tools in stroke centers. These techniques measure parameters such as cerebral blood flow (CBF), cerebral blood volume (CBV), mean transit time (MTT), and time to peak (TTP), which collectively offer a comprehensive picture of brain perfusion status.

Automated software platforms like RAPID have revolutionized the interpretation of perfusion data. By providing fast, standardized analysis of ischemic core and penumbra volumes, these tools minimize subjectivity and delay, enabling faster treatment decisions even in extended time windows (up to 24 hours from symptom onset).


Impact on Treatment Selection: 

The DEFUSE 3 and DAWN trials demonstrated that perfusion imaging can safely guide the use of thrombectomy in patients presenting beyond the traditional 6-hour window. These studies proved that imaging-based selection is superior to time-based selection, opening up treatment opportunities for a broader patient population.

Perfusion imaging also plays a role in excluding patients unlikely to benefit from invasive therapies, thereby reducing risks and optimizing resource allocation. Furthermore, ongoing research is exploring the integration of artificial intelligence (AI) to enhance image interpretation, further streamlining the workflow and reducing the need for specialist intervention.


Conclusion: Advances in perfusion imaging have reshaped the landscape of ischemic stroke management by enabling precise, tissue-based treatment selection. Through innovations in imaging modalities, automation, and software, clinicians are now better equipped to identify candidates for life-saving interventions beyond traditional time constraints. As technology continues to evolve, perfusion imaging will remain a cornerstone of personalized stroke care, driving improved outcomes and expanding access to effective treatments.

The domain www.dubaitelemedicine.com is for sale. Please contact us at www.kneetie.com

 
 
 

Comments

About Dr. Viveck Baluja and KneeTie Vascular Neurology

Dr. Viveck Baluja, MD, is a board-certified vascular neurologist (American Board of Psychiatry and Neurology — Vascular Neurology) practicing telemedicine across California, Michigan, and Colorado, with additional consultation services available to international families, particularly in India.

KneeTie offers three focused services: emergency stroke second opinions delivered within 24 hours, traumatic brain injury (TBI) consultations for survivors and caregivers, and same-day adult ADHD evaluations for residents of CA, MI, and CO.

Stroke Second Opinion

After a stroke, families often have minutes to make decisions. Dr. Baluja provides a second set of expert eyes from a board-certified vascular neurologist — reviewing imaging, hospital records, and current treatment — typically within 24 hours of request. Common questions include: Was tPA appropriate? Should we pursue thrombectomy? What is the recovery outlook? What rehabilitation makes sense?

TBI Consultation

Traumatic brain injury recovery is rarely linear. Dr. Baluja helps patients and families understand recovery timelines, treatment options, post-concussion syndrome, and red flags that warrant emergency evaluation. Consultations typically last 50 minutes and are scheduled within the same week.

Same-Day Adult ADHD Evaluation

A real evaluation by a board-certified neurologist — not a 7-minute screening. Dr. Baluja's ADHD evaluations include comprehensive history, sleep and lifestyle assessment, and behavioral strategy alongside any medication discussion. Available same-day for residents of California, Michigan, and Colorado.

Why a Vascular Neurologist?

Vascular neurology is a subspecialty focused on stroke, cerebrovascular disease, and brain blood flow — among the rarest neurology subspecialties in the U.S. Most online telehealth services use general practitioners or nurse practitioners. KneeTie is led by a board-certified vascular neurologist with full state licensure and HIPAA-compliant telehealth infrastructure.

Schedule a consultation: Use the booking calendar above to choose a service and reserve a time. For active stroke or post-tPA emergencies, email gorungo@kneetie.com directly with "URGENT" in the subject line.

© 2020 KneeTie, Jagannatha Health LLC 

bottom of page